Chris Lewis
Stock Analyst at Roth Capital
(3.09)
# 1,306
Out of 5,090 analysts
13
Total ratings
77.78%
Success rate
62.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $8.65 | -53.76% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $94.57 | -83.08% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $33.32 | -56.48% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $101.06 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $0.94 | +2,026.98% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $8.65
Upside: -53.76%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $94.57
Upside: -83.08%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $33.32
Upside: -56.48%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $101.06
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $0.94
Upside: +2,026.98%